Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
MBX Biosciences, Inc. ( (MBX) ) has shared an update.
On February 4, 2026, MBX Biosciences, Inc. closed the sale of 2,250,986 shares of its common stock through its at-the-market offering program at a volume-weighted average price of $38.76 per share, raising approximately $87.1 million in gross proceeds under its existing Open Market Sale Agreement with Jefferies. The company plans to deploy the net proceeds to fund its clinical-stage programs, broader discovery research and additional clinical development, as well as for general corporate purposes, working capital and capital expenditures, while also preserving flexibility to use remaining proceeds and existing cash to in-license, acquire or invest in complementary businesses, technologies, products or assets, and it retains capacity to sell up to an additional $62.9 million of common stock under the same facility.
The most recent analyst rating on (MBX) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on MBX Biosciences, Inc. stock, see the MBX Stock Forecast page.
Spark’s Take on MBX Stock
According to Spark, TipRanks’ AI Analyst, MBX is a Neutral.
The score is driven primarily by mixed fundamentals: strong capitalization and low leverage are outweighed by pre-revenue status, widening losses, and high cash burn. Technicals add support due to strong price trend and positive momentum, while valuation is a headwind given negative earnings and no dividend. Corporate updates are positive, highlighting pipeline progress and multi-year runway.
To see Spark’s full report on MBX stock, click here.
More about MBX Biosciences, Inc.
MBX Biosciences, Inc. is a biotechnology company focused on developing clinical-stage drug programs supported by discovery research and development activities, with operations centered on advancing its pipeline through clinical development and related R&D investment.
Average Trading Volume: 800,057
Technical Sentiment Signal: Buy
Current Market Cap: $1.72B
For detailed information about MBX stock, go to TipRanks’ Stock Analysis page.